COLLEGIUM PHARMACEUTICAL, INC — Director's Dealing 2017

Oct 27, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: COLLEGIUM PHARMACEUTICAL, INC (COLL)
CIK: 0001267565
Period of Report: 2017-10-25

Reporting Person: Fleming Alison B (Chief Technology Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-10-25	Common Stock	M	1811	$3.38	Acquired	26563	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-10-25	Stock option (right to purchase)	$3.38	M	1811	Disposed	2017-11-01	Common Stock (1811)	Direct

Footnotes

F1: All of these options were fully vested and excercisable as of October 25, 2017.